Feb 4 (Reuters) - Cigna Corp's Express Scripts has settled the U.S. Federal Trade Commission's claims its insulin pricing ...

The Trump administration announced that the company, a pharmacy benefit manager, had agreed to make significant changes to ...

The agreement orders Express Scripts to offer plan members the lowest available cost for medicine like insulin rather than ...

Express Scripts, a pharmacy benefit manager and subsidiary of Cigna (CI), has reached a settlement with the FTC over ...

The settlement comes after the FTC in September 2024 brought action against three prescription drug benefit managers, including Express Scripts, alleging the companies were artificially inflating the ...

The agreement announced Wednesday includes sweeping changes to the Cigna PBM’s business practices, including no longer ...

View Press Release: https://www.ftc.gov/news-events/news/press-releases/2026/02/ftc-secures-landmark-settlement-express-scripts-lower-drug-costs-american-patients ...

Cigna Corp's Express Scripts settled the U.S. Federal Trade Commission's claims its insulin pricing practices violated ...

The legislation will impose new restrictions on pharmacy benefit managers, giant companies like CVS Caremark, Optum Rx and ...

The settlement comes after years of meetings between NCPA and FTC staff, during which NCPA’s legal team educated government lawyers on the many egregious PBM practices that squash competition, reduce ...

The Federal Trade Commission reached a settlement with Cigna’s Express Scripts in a case over alleged inflation of insulin prices, according to a Feb. 4 agency news release. Under the settlement, ...

Members with employer-sponsored insurance saw about a 1% decrease in out-of-pocket costs for their prescription medicines last year, paying an average of $15.10 for a 30-day supply "Express Scripts ...